The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Market opportunities lie in enhancing risk-based V&V planning, focusing on DQ, IQ, OQ, and PQs to address cGMP deficiencies and regulatory expectations. By aligning with FDA, ICH, and ISO standards, ...

Revology Cars’ latest creation—the 1969 Boss 429 Mustang—uses advanced engineering to revive Ford’s iconic Mustang ...

Emburse, the company defining Expense Intelligence through AI-powered travel and spend orchestration, today announced the launch of Invoice Tax Validation, a new capability that helps finance teams ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...

Opinion: From Greenland to glory-hunting money, “peace prizes,” and more, Trump’s addiction to excess is metastasizing into a ...

Sandlin describes a company trying to remain credible in a hesitant market while adjusting to reality without tearing itself ...

TeleChat3 series – China Telecom’s TeleAI released the first large-scale Mixture-of-Experts (MoE) models trained entirely on ...

Modern vision-language models allow documents to be transformed into structured, computable representations rather than lossy text blobs.

Stratasys Ltd. faces falling sales despite strong liquidity; margins may improve via manufacturing pivot, but profits likely ...

Courts are increasingly confronting AI-generated and AI-manipulated evidence land on their dockets. But with innovation comes ...